Qu Mingyi, Fang Fang, Zou Xiaojing, Zeng Quan, Fan Zeng, Chen Lin, Yue Wen, Xie Xiaoyan, Pei Xuetao
Stem Cell and Regenerative Medicine Lab, Beijing Institute of Transfusion Medicine, Beijing 100850, China.
South China Research Center for Stem Cell and Regenerative Medicine, South China Institute Biomedicine, Guangzhou 510005, China.
Cell Death Dis. 2016 Oct 20;7(10):e2430. doi: 10.1038/cddis.2016.288.
A better understanding of the mechanisms involved in megakaryocyte maturation will facilitate the generation of platelets in vitro and their clinical applications. A microRNA, miR-125b, has been suggested to have important roles in the self-renewal of megakaryocyte-erythroid progenitors and in platelet generation. However, miR-125b is also critical for hematopoietic stem cell self-renewal. Thus, the function of miR-125b and the complex signaling pathways regulating megakaryopoiesis remain to be elucidated. In this study, an attentive examination of the endogenous expression of miR-125b during megakaryocyte differentiation was performed. Accordingly, the differentiation of hematopoietic stem cells requires the downregulation of miR-125b, whereas megakaryocyte determination and maturation synchronize with miR-125b accumulation. The overexpression of miR-125b improves megakaryocytic differentiation of K562 and UT-7 cells. Furthermore, stage-specific overexpression of miR-125b in primary cells demonstrates that miR-125b mediates an enhancement of megakaryocytic differentiation after megakaryocyte determination, the stage at which megakaryocytes are negative for the expression of the hematopoietic progenitor marker CD34. The identification of miR-125b targets during megakaryopoiesis was focused on negative regulators of cell cycle because the transition of the G1/S phase has been associated with megakaryocyte polyploidization. Real-time PCR, western blot and luciferase reporter assay reveal that p19 is a direct target of miR-125b. P19 knockdown using small interfering RNA (siRNA) in megakaryocyte-induced K562 cells, UT-7 cells and CD61 promegakaryocytes results in S-phase progression and increased polyploidy, as well as improved megakaryocyte differentiation, similarly to the effects of miR-125b overexpression. P19 overexpression reverses these effects, as indicated by reduced expression of megakaryocyte markers, G1-phase arrest and polyploidy decrease. P19 knockdown in miR-125b downregulated cells or p19 overexpression in miR-125b upregulated cells rescued the effect of miR-125b. Taken together, these findings suggest that miR-125b expression positively regulates megakaryocyte development since the initial phases of megakaryocyte determination, and p19 is one of the key mediators of miR-125b activity during the onset of megakaryocyte polyploidization.
更好地理解巨核细胞成熟所涉及的机制将有助于体外血小板的生成及其临床应用。一种微小RNA,即miR-125b,已被认为在巨核细胞-红系祖细胞的自我更新以及血小板生成中发挥重要作用。然而,miR-125b对造血干细胞的自我更新也至关重要。因此,miR-125b的功能以及调节巨核细胞生成的复杂信号通路仍有待阐明。在本研究中,我们对巨核细胞分化过程中miR-125b的内源性表达进行了仔细检测。相应地,造血干细胞的分化需要miR-125b的下调,而巨核细胞的确定和成熟与miR-125b的积累同步。miR-125b的过表达可改善K562和UT-7细胞的巨核细胞分化。此外,在原代细胞中阶段特异性过表达miR-125b表明,miR-125b在巨核细胞确定后介导巨核细胞分化增强,此时巨核细胞对造血祖细胞标志物CD34的表达呈阴性。由于G1/S期的转变与巨核细胞多倍体化相关,因此在巨核细胞生成过程中对miR-125b靶标的鉴定集中在细胞周期的负调节因子上。实时PCR、蛋白质印迹和荧光素酶报告基因检测表明p19是miR-125b的直接靶标。在巨核细胞诱导的K562细胞、UT-7细胞和CD61前巨核细胞中使用小干扰RNA(siRNA)敲低p19会导致S期进展和多倍体增加,以及巨核细胞分化改善,这与miR-125b过表达的效果相似。如巨核细胞标志物表达降低、G1期停滞和多倍体减少所示,p19的过表达可逆转这些效应。在miR-125b下调的细胞中敲低p19或在miR-125b上调的细胞中过表达p19可挽救miR-125b的效应。综上所述,这些发现表明,自巨核细胞确定的初始阶段起,miR-125b的表达正向调节巨核细胞发育,并且p19是巨核细胞多倍体化开始时miR-125b活性的关键介质之一。